Recombinant Chicken Protein Sidekick-2 (SDK2), partial, is a recombinant protein derived from the Sidekick Cell Adhesion Molecule 2 gene. This protein is part of the immunoglobulin superfamily and contains two immunoglobulin domains and thirteen fibronectin type III domains . The SDK2 protein is similar to the Drosophila sidekick gene product, suggesting a role in cell adhesion and potentially in neural circuit formation .
Origin: The protein is derived from chicken.
Host/Reactivities: It can be expressed in various hosts such as E. coli, yeast, baculovirus, or mammalian cells .
Purity: The purity of this recombinant protein is typically greater than or equal to 85%, as determined by SDS-PAGE .
Function: While the specific function of SDK2 is not fully understood, it is believed to play a role in cell adhesion, similar to other members of the immunoglobulin superfamily .
In Drosophila, Sidekick proteins are localized to specific synaptic layers and are necessary for the proper alignment and sorting of photoreceptor axons . While similar localization patterns in chickens have not been extensively studied, the presence of SDK2 in retinal circuits suggests potential roles in visual processing.
Recombinant SDK2 proteins can be used in various research applications, including antibody production, ELISA assays, and as positive controls in other antibody assays . They may also serve as tools for studying neural development and circuit formation.
| Characteristic | Description |
|---|---|
| Origin | Chicken |
| Host/Reactivities | E. coli, Yeast, Baculovirus, Mammalian Cells |
| Purity | ≥ 85% (SDS-PAGE) |
| Function | Cell Adhesion |
| Domains | 2 Immunoglobulin, 13 Fibronectin Type III |
| Protein Type | Host | Purity | Application |
|---|---|---|---|
| Human SDK2 | HEK293 | > 80% | Antibody Production, ELISA |
| Chicken SDK2 | Various | ≥ 85% | Research, Antibody Assays |
| Mouse SDK2 | Various | ≥ 85% | Research, Antibody Assays |
STRING: 9031.ENSGALP00000037694
UniGene: Gga.118
What is the structure and function of chicken Sidekick-2 (SDK2) protein?
Chicken SDK2 is a transmembrane adhesion molecule belonging to the immunoglobulin superfamily. Its structure consists of:
Six immunoglobulin (Ig) domains
Thirteen fibronectin type III (FnIII) domains
A transmembrane domain
A cytoplasmic region with a PDZ-binding motif
SDK2 functions primarily as a homophilic adhesion molecule, meaning it binds to other SDK2 proteins. Research has demonstrated that the first and second Ig domains are necessary and sufficient to mediate this homophilic adhesion .
The structural organization of SDK2 is crucial for its functional roles:
The Ig-like domains mediate homophilic trans-interactions between adjacent cells
The FnIII domains interact with lipid membranes, contributing to tight cell-cell adhesion
This architecture enables SDK2 to play key roles in neural development, particularly in the establishment of lamina-specific synaptic connectivity in the visual system .
How is SDK2 expression regulated during development in various tissues?
SDK2 expression follows a tight spatial and temporal regulation pattern during development:
Neural Tissue:
In retinal development, SDK2 is expressed in non-overlapping subsets of retinal neurons compared to SDK1
SDK2 is localized to specific synaptic layers of developing motion detection circuits
Expression is particularly high in VG3 amacrine cells and their synaptic partners
Non-Neural Tissues:
During kidney development, SDK2 shows expression patterns similar to genes involved in branching morphogenesis
Expression begins in ureteric bud and ureteric bud-derived tissues
In mature kidneys, expression levels are relatively low in normal conditions but can be upregulated in disease states
Developmental Timing:
Developmental regulation of SDK2 expression involves:
Initial expression in progenitor populations
Refinement to specific cell types during differentiation
Localization to synaptic sites during circuit formation
What experimental techniques are most effective for studying SDK2 expression patterns?
Several complementary techniques have proven effective for studying SDK2 expression:
Transcriptomic Approaches:
Single-cell RNA sequencing (scRNA-seq) has been particularly valuable for identifying cell types expressing SDK2 in complex tissues like the retina
This method revealed that SDK2 is expressed in specific amacrine cell populations and direction-selective T4/T5 cells
Northern blot analysis can detect the presence of SDK2 mRNA in different tissues during development
Protein Detection Methods:
Immunohistochemistry using anti-SDK2 antibodies for tissue localization
Western blotting for quantifying protein levels across tissues and developmental stages
Protein trap methods that insert reporters into the endogenous SDK2 locus
Genetic Labeling Approaches:
The eCHIKIN method (enhanced CRISPR-mediated homology-directed knock-in) has been successfully used to insert reporters or Cre recombinase into the SDK2 gene
This approach allows visualization of SDK2-expressing cells and their morphology without generating transgenic lines
Example protocol for eCHIKIN targeting of SDK2:
Design guide RNAs targeting the SDK2 locus
Create a single-strand DNA containing a reporter sequence flanked by ~70 bases of SDK2-specific homology arms
Deliver a mixture of guide RNAs, Cas9 protein, and the reporter construct via in ovo electroporation
Add spectrally distinct reporter/transposase constructs to monitor electroporation efficiency
What methodological challenges exist in producing functional recombinant chicken SDK2 protein, and how can they be overcome?
Production of functional recombinant chicken SDK2 presents several significant challenges:
Structural Complexity Challenges:
The large size (~200 kDa) and multiple domains (6 Ig domains, 13 FnIII domains) make full-length expression difficult
Proper folding of multiple Ig domains requires specialized chaperones
Extensive disulfide bonding in Ig domains necessitates oxidizing environments
Expression System Considerations:
Bacterial systems typically fail to produce properly folded SDK2 due to lack of post-translational modifications
Mammalian cell expression systems generally yield higher quality protein
CHO or HEK293 cells are preferred for maintaining proper glycosylation patterns
Methodological Solutions:
Domain-by-domain approach: Express individual domains or domain pairs to overcome folding challenges
Fusion protein strategies: Create fusion proteins with well-folded partners (e.g., Fc fragments) to enhance solubility
Specialized secretion systems: Use dedicated secretion signals optimized for complex proteins
Partial constructs: Focus on producing the first two Ig domains, which are sufficient for homophilic binding
Purification Optimization:
Use affinity tags (His-tag) positioned to avoid interference with binding domains
Implement multi-step purification protocols involving:
Affinity chromatography (e.g., Ni-NTA for His-tagged proteins)
Ion exchange chromatography to separate properly folded from misfolded species
Size exclusion chromatography as a final polishing step
Research indicates >80% purity can be achieved through optimized protocols, though yields remain challenging for full-length protein .
How can researchers validate the homophilic binding properties and functionality of recombinant SDK2?
Validating homophilic binding and functionality of recombinant SDK2 requires multiple complementary approaches:
Cell Aggregation Assays:
Transfect cells (e.g., HEK293T) with SDK2 expression constructs
Mix cells expressing SDK2 with control cells or cells expressing other adhesion molecules
Quantify aggregation patterns to confirm homophilic specificity
This approach has demonstrated that cells expressing SDK2 form separate aggregates from SDK1-expressing cells
Domain Deletion Studies:
Generate constructs lacking specific domains (e.g., first or second Ig domains)
Compare adhesion properties to wild-type SDK2
Studies show deletion of the second Ig domain or the QLVILA sequence within it abolishes adhesion
Chimeric Protein Analysis:
Create chimeric proteins where the first two Ig domains of SDK1 are replaced with those of SDK2 and vice versa
Test if these chimeras form aggregates with cells expressing the respective full-length proteins
This approach has confirmed that the first two Ig domains are necessary and sufficient for homophilic binding specificity
Biophysical Characterization:
Surface Plasmon Resonance (SPR) to measure binding kinetics between purified SDK2 proteins
Analytical Ultracentrifugation to assess oligomerization state
Circular Dichroism to confirm proper protein folding
Electron microscopy to visualize SDK2-mediated adhesion interfaces and protein organization between cell membranes
What are the most effective gene editing approaches for studying SDK2 function in avian systems?
Several gene editing approaches have proven effective for studying SDK2 function in avian systems:
CRISPR/Cas9-Based Methods:
The CRISPR/Cas9 system has revolutionized gene editing in chickens through several approaches:
Direct embryo editing:
Cell line editing:
Primordial germ cell (PGC) editing:
Homology-Directed Repair Strategies:
The eCHIKIN method (enhanced CRISPR-mediated homology-directed knock-in) has been particularly successful:
Uses guide RNAs, Cas9 protein, and single-strand DNA with ~70bp homology arms
Allows reporter insertion at the SDK2 locus to visualize expression patterns
Can be used to introduce specific mutations to study domain functions
Success rates of approximately 80% have been reported for targeted insertions
Methodological Considerations:
Co-electroporation with piggyBac transposon reporters enables monitoring of transfection efficiency
Optimization of reagents to enhance homologous recombination is critical
The timing of editing is crucial for studying developmental functions of SDK2
How do epigenetic factors and post-translational modifications regulate SDK2 function in different cellular contexts?
The regulation of SDK2 function through epigenetic factors and post-translational modifications represents an emerging area of research:
Epigenetic Regulation:
Comparative transcriptomic analyses of chicken tissues reveal differential SDK2 expression that cannot be explained by genetic differences alone
ChIP-seq studies in developing neural tissues suggest regulation by tissue-specific transcription factors
Methylation patterns at the SDK2 promoter correlate with expression levels across different cell types
Histone modifications, particularly H3K27ac and H3K4me3 marks, have been associated with active SDK2 transcription in expressing cells
Post-Translational Modifications:
Glycosylation: Multiple N-glycosylation sites on the extracellular domains affect protein stability and binding properties
Phosphorylation: The cytoplasmic domain contains conserved phosphorylation sites that may regulate interactions with scaffolding proteins
PDZ Domain Interactions: The C-terminal PDZ-binding motif of SDK2 interacts with scaffolding proteins like MAGI family members
Proteolytic Processing: Evidence suggests regulated cleavage events may generate soluble forms with distinct functions
Methodological Approaches for Study:
Mass spectrometry to identify specific modification sites
Site-directed mutagenesis to assess functional importance of modifications
Pharmacological inhibitors of specific enzymes (kinases, glycosyltransferases)
Comparison of modifications across developmental stages and disease states
Cellular Context Differences:
Research indicates that SDK2 modifications differ between:
Neural versus epithelial cells
Developing versus mature tissues
Normal versus pathological conditions (e.g., upregulation in certain kidney diseases)
How can researchers resolve contradictory data regarding SDK2 localization and function between different experimental systems?
Resolving contradictory data about SDK2 localization and function requires systematic approaches:
Sources of Experimental Discrepancies:
Species Differences: Despite structural conservation, SDK2 functions differently between vertebrates and Drosophila
Developmental Timing: SDK2 localization varies significantly across developmental stages
Methodology Variations: Different antibodies, fixation methods, and detection techniques yield contradictory results
Splice Variants: Alternative splicing generates SDK2 variants with distinct localization patterns
Systematic Resolution Approaches:
Cross-Species Comparative Analysis:
Directly compare SDK2 localization and function in multiple species under identical experimental conditions
Identify species-specific binding partners that may account for functional differences
Example finding: SDK2 is required for photoreceptors in Drosophila but for specific interneurons in vertebrates
Multi-Method Validation:
Functional Domain Mapping:
Standardized Data Reporting:
Detailed documentation of experimental conditions
Sharing of reagents and protocols between labs
Publication of negative results to complete the understanding of variability
Case Study Resolution Example:
Contradictory data regarding SDK2's role in retinal circuit formation has been resolved by determining that:
In Drosophila, SDK2 functions primarily in photoreceptors to promote lamina neuron alignment
In vertebrates, SDK2 functions in retinal interneurons to establish synaptic specificity
The molecular mechanisms (homophilic adhesion) are conserved, while the cellular contexts differ
What experimental models are best suited for studying the developmental role of SDK2 in neural circuit formation?
The study of SDK2's role in neural circuit formation benefits from multiple complementary experimental models:
Avian Models:
Chicken embryos offer excellent accessibility for in ovo manipulations
Allow developmental studies from early neural specification through circuit formation
Electroporation techniques enable targeted gene manipulation in specific neuronal populations
The visual system develops rapidly and is amenable to both structural and functional analyses
SDK2's role in direction-selective circuits can be studied through combined genetic manipulation and functional imaging
Advantages of chicken models include:
Rapid development (21 days to hatching)
Large embryos enabling precise surgical manipulations
Established electroporation protocols for gene delivery
Compatibility with two-photon imaging of developing circuits
Well-characterized visual system with analogous circuits to mammals
In Vitro Models:
Retinal explant cultures maintain cellular architecture while allowing manipulation and imaging
Dissociated retinal neurons can form synapses in culture, enabling molecular studies of SDK2's role in synaptogenesis
Organoid models derived from stem cells recapitulate aspects of retinal development
Functional Assessment Techniques:
Electrophysiology: Patch-clamp recordings from identified SDK2-expressing neurons
Calcium imaging: Monitoring activity in intact circuits before and after SDK2 manipulation
Behavioral assays: Optomotor responses can assess visual motion detection circuit function
Experimental Design Considerations:
Timing of SDK2 manipulation is critical (early knockout may cause developmental compensation)
Cell-type specificity is essential (global knockouts may have indirect effects)
Combined structural and functional readouts provide the most comprehensive assessment
A recommended experimental workflow combines:
scRNA-seq to identify SDK2-expressing cell types
CRISPR-based labeling to visualize those cells (eCHIKIN method)
Cell-type specific manipulation of SDK2 expression
How does the function of recombinant SDK2 compare in different expression systems, and what quality control measures ensure experimental reproducibility?
The function of recombinant SDK2 varies significantly across expression systems, necessitating rigorous quality control:
Comparison of Expression Systems:
| Expression System | Advantages | Limitations | Modifications | Yield |
|---|---|---|---|---|
| Mammalian Cells (HEK293) | Proper folding, glycosylation | Higher cost, slower | Closest to native | Moderate |
| Insect Cells (Sf9) | Higher yields, proper folding | Different glycosylation | Simpler sugars | High |
| Yeast (Pichia) | Low cost, high density | Hyperglycosylation | High mannose | Variable |
| Bacterial (E. coli) | Simplicity, low cost | Poor folding, no glycosylation | None | High (but inactive) |
Critical Quality Control Measures:
Structural Validation:
Circular dichroism to confirm secondary structure
Size-exclusion chromatography to assess aggregation state
Thermal shift assays to evaluate stability
Limited proteolysis to verify domain folding integrity
Functional Validation:
Batch Consistency Measures:
Lot-to-lot testing with standardized functional assays
Reference standards for each production method
Detailed documentation of expression conditions
Storage stability testing at different temperatures
Reproducibility Challenges and Solutions:
The most common reproducibility issues include:
Variable glycosylation affecting binding properties
Inconsistent folding of multi-domain proteins
Aggregation during storage and handling
Loss of activity upon freeze-thaw cycles
Recommended best practices to ensure reproducibility:
Use the same expression system consistently across experiments
Implement quality thresholds for purity (>80%), activity, and homogeneity
Aliquot protein to avoid repeated freeze-thaw cycles
Include positive controls from characterized batches in new experiments
Report detailed methods including expression system, purification protocol, and quality control results
When comparing results from different laboratories, researchers should account for variations in SDK2 source and quality, as these factors significantly impact experimental outcomes.